Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing.  Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing.  Oppose reductions to Medicare Clinical Laboratory Fee Schedule. Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDS initiatives to regulate laboratory-developed diagnostic tests; legislation concerning regulation of laboratory-developed diagnostic tests (including H.R. 3207); support taking essential steps for Testing Act (H.R. 6118; S. 3391).
MMM - Medicare/Medicaid MED - Medical/Disease Research/Clinical Labs
135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
STONE MATTHEIS XENOPOULOS AND BREW, PC
1025 THOMAS JEFFERSON STREET, NW. #800 W, WASHINGTON, DC, 20007, US
MICHAEL N MCCARTY PATRICK BURCHETTE MICHAEL N MCCARTY PATRICK BURCHETTE